{
    "attributes": {
        "action": "Call for reassessment of the Cancer Drugs Fund for blood cancer patients",
        "additional_details": "This is a petition on behalf of blood cancer patients who are concerned about the recent changes made to the Cancer Drugs Fund.\r\nIt was announced on Monday, January 12, 2015, that life-extending cancer drugs are to be removed from a list of medicines that are approved for funding via the Cancer Drugs Fund.\r\n\r\nThis petition calls specifically for a rethink over the de-listing of the following drugs:\r\nBosutinib and Dasatinib for blast-phase Chronic Myeloid Leukaemia;\r\nThe de-listing of Bortezomib for relapsed Myeloma, Mantle-Cell Lymphoma and Waldenstrom Macroglobulinemia;\r\nThe de-listing of Bendamustine for non-Hodgkin Lymphoma;\r\nThe de-listing of Ofatumumab for relapsed or refractory Chronic Lymphatic Leukaemia;\r\nA re-analysis of the decision to reject Vemurafenib for all Hairy Cell Leukaemia patients and also a re-analysis of the rejection of Idelalisib for Chronic Lymphatic Leukaemia.",
        "background": null,
        "closed_at": "2015-03-30T22:59:59.000Z",
        "created_at": "2015-01-16T00:43:39.000Z",
        "debate": null,
        "debate_outcome_at": null,
        "debate_threshold_reached_at": null,
        "government_response": null,
        "government_response_at": null,
        "moderation_threshold_reached_at": "2015-01-16T00:43:39.000Z",
        "opened_at": "2015-01-16T07:57:44.000Z",
        "rejected_at": null,
        "rejection": null,
        "response_threshold_reached_at": null,
        "scheduled_debate_date": null,
        "signature_count": 730,
        "state": "closed",
        "updated_at": "2017-06-21T15:16:44.073Z"
    },
    "id": 73868,
    "links": {
        "self": "https://petition.parliament.uk/archived/petitions/73868.json"
    },
    "type": "archived-petition"
}